Conclusively, we demonstrated that the tumor region, containing both the stroma and the epithelium, was superior to either the pure epithelium or the pure stroma in predicting treatment response and proposed an integrated model, the IPM, which is highly effective for the early prediction of breast cancer patients’ response to NAT. Here, BRD2 is linked to breast cancer.